Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Other Working Capital Changes (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Other Working Capital Changes data on record, last reported at $1.7 million in Q3 2025.

  • For Q3 2025, Other Working Capital Changes rose 350.9% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $2.8 million, up 527.31%, while the annual FY2024 figure was -$13000.0, 137.14% down from the prior year.
  • Other Working Capital Changes reached $1.7 million in Q3 2025 per TNXP's latest filing, up from -$134000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.7 million in Q3 2025 and bottomed at -$668000.0 in Q3 2024.
  • Average Other Working Capital Changes over 3 years is $198272.7, with a median of $11000.0 recorded in 2023.
  • Peak YoY movement for Other Working Capital Changes: plummeted 4029.41% in 2024, then soared 30750.0% in 2025.
  • A 3-year view of Other Working Capital Changes shows it stood at $11000.0 in 2023, then surged by 5872.73% to $657000.0 in 2024, then surged by 155.1% to $1.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $1.7 million in Q3 2025, -$134000.0 in Q2 2025, and $617000.0 in Q1 2025.